The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage II/III gastric cancer.

Zhou, Xin; Du, Yiping; Xu, Jun; Huang, Zebo; Qiu, Tianzhu; Wang, Xiaping; Qian, Jiaqi; Zhu, Wei; Liu, Ping

Zhou, Xin; Du, Yiping; Xu, Jun; Huang, Zebo; Qiu, Tianzhu; Wang, Xiaping; Qian, Jiaqi; Zhu, Wei; Liu, Ping.

Affiliation

Zhou X; Department of Oncology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China.

Tumour Biol ; 35(11): 11659-66, 2014 Nov.

Article in En | MEDLINE | ID: mdl-25139101

Subject(s)

Lymphocytes/pathology; Monocytes/pathology; Neoplasm Recurrence, Local/pathology; Stomach Neoplasms/pathology; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local/mortality; Neoplasm Recurrence, Local/therapy; Neoplasm Staging; Preoperative Care; Prognosis; ROC Curve; Retrospective Studies; Stomach Neoplasms/mortality; Stomach Neoplasms/therapy; Survival Rate

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Lymphocytes / Monocytes / Neoplasm Recurrence, Local Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Tumour Biol Journal subject: NEOPLASIAS Year: 2014 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google